# Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

> **NCT04047849** · PHASE4 · RECRUITING · sponsor: **Woman's** · enrollment: 34 (estimated)

## Conditions studied

- Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture)
- Rupture of Membranes; Premature
- Rupture of Membranes; Premature, Affecting Fetus
- Preterm Birth
- Preterm PROM (Pregnancy)
- Preterm Labor

## Interventions

- **DRUG:** Antibiotics, oral Azithromycin and oral Amoxicillin

## Key facts

- **NCT ID:** NCT04047849
- **Lead sponsor:** Woman's
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-28
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04047849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04047849, "Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04047849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*